Cargando…
Non-small cell lung cancer with iris metastasis controlled with osimertinib and monthly intravitreal bevacizumab
PURPOSE: Iris metastases from lung cancer occur rarely. Current treatment options such as surgical iridectomy or radiotherapy are invasive and can potentially lead to negative side effects. Other less invasive alternatives include chemotherapy and intracameral bevacizumab. OBSERVATIONS: An 81 year-o...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790597/ https://www.ncbi.nlm.nih.gov/pubmed/35112017 http://dx.doi.org/10.1016/j.ajoc.2022.101269 |